KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Net Margin (2020 - 2025)

Hims & Hers Health (HIMS) has disclosed Net Margin for 6 consecutive years, with 3.33% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 207.0% to 3.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.47% through Dec 2025, down 307.0% year-over-year, with the annual reading at 5.47% for FY2025, 307.0% down from the prior year.
  • Net Margin hit 3.33% in Q4 2025 for Hims & Hers Health, up from 2.63% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 18.82% in Q3 2024 to a low of 98.26% in Q1 2021.
  • Historically, Net Margin has averaged 9.07% across 5 years, with a median of 3.39% in 2023.
  • Biggest five-year swings in Net Margin: plummeted -7819bps in 2021 and later surged 8222bps in 2022.
  • Year by year, Net Margin stood at 36.79% in 2021, then soared by 82bps to 6.52% in 2022, then surged by 108bps to 0.5% in 2023, then surged by 971bps to 5.41% in 2024, then tumbled by -38bps to 3.33% in 2025.
  • Business Quant data shows Net Margin for HIMS at 3.33% in Q4 2025, 2.63% in Q3 2025, and 7.8% in Q2 2025.